文献速递前列腺癌

磁共振成像靶向前列腺穿刺活检时是否应对经直肠超声低回声病灶进行采样

Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy?
PubMed 文献 · Urology · 2016-11-15

该研究纳入2007年8月至2015年2月前瞻性试验中接受MRI-经直肠超声融合靶向穿刺的男性,比较仅穿刺MRI病灶与附加穿刺低回声超声病灶(HUL)对前列腺癌检出及分级的影响,发现附加HUL穿刺使高级别(ISUP 3-5级)前列腺癌检出小幅增加,但仅1例(队列1%)为仅MRI穿刺会漏诊,96%患者风险分组不变。

要点

  • 106例男性共119个HUL接受穿刺,52/106(49%)经MRI病灶或HUL穿刺诊断前列腺癌。
  • 附加HUL穿刺较仅MRI病灶穿刺多检出4例高级别(ISUP 3-5级)前列腺癌(20 vs 16例,P = .046)。
  • 附加HUL穿刺未改变96%(102/106)HUL男性的前列腺癌风险分组。

核心结论

  • 与仅穿刺MRI病灶相比,附加穿刺HUL可使较高级别前列腺癌检出小幅增加。
  • 由于升级罕见,在MRI靶向穿刺中常规筛查HUL仍有争议。

研究设计与样本

  • 研究为正在进行的 prospective trial 的一部分,患者接受MRI-经直肠超声(TRUS)融合靶向穿刺。
  • 入组时间为2007年8月至2015年2月,试验共1260例男性,其中106例接受119个HUL的穿刺。
  • HUL与MRI病灶的穿刺病理按2014年国际泌尿病理学会(ISUP)更新分级系统分类,比较附加与不附加HUL穿刺对前列腺癌的检出。

主要发现

  • 106例男性中52例(49%)经MRI病灶或HUL穿刺诊断前列腺癌。
  • 附加HUL穿刺较仅MRI病灶穿刺多检出4例高级别(ISUP 3-5级)前列腺癌(20 vs 16例,P = .046)。
  • 4例中3例为仅MRI引导穿刺所诊断的低级别(ISUP 1-2级)前列腺癌升级而来,仅1例(队列1%)为仅MRI引导穿刺会漏诊。
  • 附加HUL穿刺未改变96%(102/106)HUL男性的前列腺癌风险分组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether supplemental biopsy of hypoechoic ultrasound lesions (HUL) incidentally found during magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion-targeted prostate biopsy results in improved prostate cancer (PCa) detection. METHODS: Patients underwent MRI-TRUS-targeted biopsy as part of an ongoing prospective trial from August 2007 to February 2015. For men with HUL, the biopsy pathology of HUL and MRI lesions was classified according to the updated 2014 International Society of Urological Pathology (ISUP) grading system. The detection of PCa by MRI-targeted biopsy with and without HUL biopsy was compared. RESULTS: Of 1260 men in the trial, 106 underwent biopsy of 119 HULs. PCa was diagnosed in 52 out of 106 men (49%) by biopsy of either MRI lesions or HUL. Biopsy of HUL in addition to MRI lesions resulted in 4 additional diagnoses of high-grade (ISUP grades 3-5) PCa versus biopsy of MRI lesions alone (20 vs 16 men, P = .046). Three of these cases were upgraded from lower grade (ISUP grades 1-2) PCa on MRI-guided biopsy alone, and only 1 case (1% of cohort) was diagnosed that would have been missed by MRI-guided biopsy alone. Supplemental biopsy of HUL did not change the PCa risk category in 96% (102 out of 106) of men with HUL. CONCLUSION: Supplemental biopsy of HUL yields a small increase in the detection of higher grade PCa as compared with biopsy of MRI lesions alone. As upgrading is rare, routinely screening for HUL during MRI-targeted biopsy remains controversial.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Shakir NA, Siddiqui MM, George AK, et al. Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy? Urology. 2016. PMID: 27864107. doi:10.1016/j.urology.2016.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。